ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $948,000 | +3.6% | 177,213 | +9.0% | 0.00% | 0.0% |
| Q3 2016 | $915,000 | +5.8% | 162,585 | +3.2% | 0.00% | 0.0% |
| Q2 2016 | $865,000 | -24.1% | 157,531 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $1,139,000 | -8.6% | 153,508 | +2.4% | 0.00% | 0.0% |
| Q4 2015 | $1,246,000 | +18.4% | 149,930 | +28.4% | 0.00% | 0.0% |
| Q3 2015 | $1,052,000 | -32.8% | 116,731 | -10.5% | 0.00% | -50.0% |
| Q2 2015 | $1,565,000 | +136.0% | 130,393 | +112.0% | 0.00% | +100.0% |
| Q1 2015 | $663,000 | +166.3% | 61,518 | +25.0% | 0.00% | – |
| Q4 2014 | $249,000 | +72.9% | 49,199 | -9.9% | 0.00% | – |
| Q3 2014 | $144,000 | -35.7% | 54,623 | -1.7% | 0.00% | – |
| Q2 2014 | $224,000 | -21.1% | 55,561 | -10.5% | 0.00% | – |
| Q1 2014 | $284,000 | +14.1% | 62,096 | +8.2% | 0.00% | – |
| Q4 2013 | $249,000 | +38.3% | 57,399 | +26.0% | 0.00% | – |
| Q3 2013 | $180,000 | +87.5% | 45,568 | -0.1% | 0.00% | – |
| Q2 2013 | $96,000 | – | 45,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |